Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Beovu Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The growth observed historically resulted from the increasing prevalence of age-related macular degeneration, the rise in diabetic eye diseases, the early adoption of anti-VEGF therapies, the expansion of ophthalmology clinics, and enhanced retinal diagnostics.
The anticipated growth during the forecast period is propelled by a global increase in the elderly population, a rise in diabetes prevalence, the demand for long-lasting treatments, enhanced retinal screening initiatives, and the expansion of outpatient care. Noteworthy trends projected for this period encompass the increased adoption of anti-VEGF therapies, a preference for longer dosing intervals, a growing need for retinal disease treatments, the broadening of outpatient ophthalmic services, and an emphasis on preserving vision among aging populations.
Get A Free Sample Report With In-Depth Market Insights:
Beovu Market Growth Drivers: What’s Behind The Acceleration?
The increasing occurrence of retinal conditions is anticipated to stimulate the expansion of the beovu market in the coming years. Retinal diseases encompass various ailments impacting the retina, the ocular tissue responsible for light sensitivity, including conditions like age-related macular degeneration (AMD), diabetic retinopathy, retinal detachment, and macular edema, frequently resulting in impaired vision. The surge in these conditions stems from demographic shifts towards older populations, a growing number of diabetes diagnoses, extended periods of screen use, and genetic predispositions, contributing to higher rates of vision loss and blindness. Beovu addresses retinal diseases by blocking VEGF, thereby diminishing fluid leakage and swelling within the retina, which assists in enhancing vision, preventing further disease progression, and improving patient results for issues such as wet AMD and diabetic macular edema. For example, data from the National Eye Institute, a US-based government agency, shows that 2.7 million Americans currently live with glaucoma, with a projected rise to 4.3 million by 2030. Furthermore, 7.7 million Americans are impacted by diabetic retinopathy, a number expected to grow to 11.3 million by 2030. Consequently, the increasing prevalence of retinal diseases is a key factor driving growth in the beovu market. The expanding demographic of older adults is anticipated to fuel the future growth of the beovu market. The term “geriatric population” identifies individuals typically aged 65 and above, encompassing seniors who may undergo a range of age-related health, social, and functional alterations. The increase in this demographic is linked to progress in healthcare, enhanced living standards, better dietary habits, and longer life expectancies. Beovu (brolucizumab) supports the geriatric population by addressing age-related macular degeneration (AMD), a frequent cause of vision loss among seniors, through reducing retinal fluid buildup and aiding in vision stabilization or improvement. For example, the UK Parliament’s House of Commons Library, a UK-based government administration, reported in July 2024 that in 2022, 12.7 million individuals aged 65 or over resided in the UK, making up 19% of the total populace. This figure is forecast to reach 22.1 million by 2072, constituting 27% of the population. Thus, the expanding geriatric population is a significant factor in the growth of the beovu market.
Beovu Market Segment Performance And Emerging Opportunities
The beovu market covered in this report is segmented –
1) By Type: Macular Degeneration, Diabetic Retinopathy, Other Types
2) By Dosage Form: Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
4) By End User: Adult, Geriatric
Beovu Market Key Players: Which Companies Lead Industry Competition?
Major companies operating in the beovu market are Novartis AG
View The Full Beovu Market Report:
Beovu Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the beovu market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the beovu market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
